openPR Logo
Press release

Injectable Drug Delivery Market Global Research and Analysis 2025

08-24-2017 03:12 PM CET | Health & Medicine

Press release from: TMR Research

Injectable Drug Delivery Market Global Research and Analysis

Global Injectable Drug Delivery Market: Overview

Injectable drug delivery is the process of administering drugs into a patient’s body through injection-based delivery devices. It allows maximum bioavailability at a rapid transportation of the pharmaceutical drug as it bypasses the first pass metabolism. Thus, it is considered to be one of the most effective routes of administration. Some of the common routes for this type of drug delivery are intramuscular, intravenous, intracardiac, intraarterial, intradermal, subcutaneous, intrathecal, and intraperitoneal. Injectable drug delivery systems find their application in autoimmune diseases, orphan diseases, hormonal disorders, and cancer.

Global Injectable Drug Delivery Market: Key Trends

The growing incidence of chronic diseases such as cancer and diabetes is translating into the greater global demand for injectable drug delivery systems. Rapid technological advancements and increasing focus on new product launches are ensuring that the systems being manufactured and marketed are built so as to meet the specific needs of the patients. This, in turn, is working in favor of the growth of the global injectable drug delivery market. Players in the market are also benefitting from the flourishing growth of the biologics market. Moreover, the surging demand for self-injection devices is stoking the growth of the market.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=1871

However, the infections associated with needlestick injuries and their growing occurrence are keeping the market from realizing its utmost potential. Furthermore, the uncertainties related to reimbursement scenario are acting as an impediment to the growth of the market.

Global Injectable Drug Delivery Market: Market Potential

The development of novel injectable drugs has given the global injectable drug delivery market a major boost. The impact of this driver will be high in the near future with several pharmaceutical giants attempting to widen their pipelines into injectable drugs. For instance, Dr. Reddy’s Laboratories Ltd. in October 2016 announced its association with Gland Pharma Ltd. for marketing and distribution of eight injectable abbreviated new drug applications in the U.S.

In addition, market players are acquiring or forming partnerships with injectable drug manufacturers to maximize their revenue generation. To put this in perspective, in December 2016, Baxter International purchased three manufacturing facilities and a diverse portfolio of 11 approved injectable drugs from Claris Lifesciences.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=1871

Global Injectable Drug Delivery Market: Region-wise Outlook

The key segments analyzed based on geography are North America, Latin America, the Middle East and Africa, Asia Pacific, and Europe. North America will be a prominent destination for players in the global injectable drug delivery. The wide base of patients suffering from autoimmune disorders and chronic diseases such as cancer and diabetes is one of the primary factors propelling the growth of the region. The continuous technological advancements and research activities in the field is also providing a competitive edge to the region over other regions.

Asia Pacific is expected to post a noteworthy CAGR during the review period. The increasing partnerships between global participants and local players are providing a significant momentum to the market in the region. The growth of the region can also be attributed to the sizeable investments in research and development in the healthcare and pharmaceutical sectors. Emerging countries such as China and India will be at the forefront of growth, owing to the rising healthcare awareness and improving healthcare infrastructure.

Get a discount @ www.tmrresearch.com/sample/sample?flag=D&rep_id=1871

Global Injectable Drug Delivery Market: Competitive Landscape

Players are allocating substantial funds for research and development activities to introduce innovative drug delivery systems in order to enhance their visibility in the global injectable drug delivery market. Mergers and acquisitions are commonly adopted growth strategies by key market participants to consolidate their presence. Some of the prominent companies operating in the market are Becton, Dickinson and Company, Nova Nordisk A/S, Baxter International, Sanofi, Pfizer, Schott AG, Eli Lilly and Company, and Terumo Corporation.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact :

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Injectable Drug Delivery Market Global Research and Analysis 2025 here

News-ID: 684350 • Views: 113

More Releases from TMR Research

Sucralose Market is Booming Worldwide | Evolva Holding, JK Sucralose, Galam Ltd.
Global Sucralose Market: Overview Increased disposable income among expanding base of urban population is stroking the food and beverage industry, but at the same time, obesity, diabetes, and heart diseases are becoming more ubiquitous than ever before. In these times, the demand for artificial sweeteners that can adequately match the taste buds of consumers with minimal quantity is being extended by the food manufacturers. Consequently, the demand for sucralose is on
Cataract Market By Major Players, Development, Opportunities, Market Driving For …
Global Cataract Market: Overview A cataract is an ocular disease in which the lens of an individual’s eye degrades progressively and turns opaque, resulting in blurred vision. If ignored, the condition can lead to vision loss. Cataracts progress slowly with age and people commonly do not realize that they are suffering from cataract as it grows very slowly and may not impede the vision immediately. Order Brochure for more Detailed Information
Fungal Infections Market (2017-2025) thriving worldwide by - Samyang Corporation …
Global Fungal Infections Market: Overview Fungi, which includes yeasts, molds, and mildews are some of the common parasites that infect different parts of the human body. Lungs, genitals, skin, digestive tract, liver, and other tissues are commonly affected by fungal infections. There are some rare types of fungal infections such as fungal keratitis, mucormycosis, and hisptoplasmosis for which treatment is not available. This has led many fungal infections market players
Diffuse Large B-Cell Lymphoma Market Sales Volume, Status, Growth, Opportunities …
Diffuse Large B-Cell Lymphoma Market: Overview With a noticeable rise in the prevalence of diffuse large B-cell lymphoma (DLBCL), the market for DLBCL market is witnessing strong growth across the world. Analysts expect the trend to remain so over the next few years, owing to the increasing number of elderly people, the most prone to DLBCL segment of the overall population. Diffuse large B-cell lymphoma (DLBCL) is the most common

All 5 Releases


More Releases for Injectable

Global Specialty Injectable Generics Market Research Report
This report studies the global Specialty Injectable Generics market status and forecast, categorizes the global Specialty Injectable Generics market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Fresenius Mylan N.V. Teva Pharmaceutical Hikma Pharmaceuticals Novartis AG Uman Pharma Baxter Par Pharmaceutical
Global Injectable Drug Delivery Market to 2028 |Retail Pharmacies, Injectable Dr …
Market Research Hub (MRH) has carefully analyzed this research study titled Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028, which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Injectable Drug Delivery. Readers can gain knowledge related to prime
Global and Chinese Sterile Injectable Drugs Market
https://www.qandqmarketresearch.com/reports/sterile-injectable-drugs2018-market-4 The Global and Chinese Sterile Injectable Drugs Industry, 2013-2023 Market Research Report is a professional and indepth study on the current state of the global Sterile Injectable Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sterile Injectable Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report
Injectable Targeted Therapy Market: Primary application of injectable targeted t …
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of
Global Facial Injectable Market – Forecast, 2013-2021
Facial Injectable Market Wiseguyreports.Com Adds “Facial Injectable Market -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Description: Facial Injectable products, also known as dermal fillers are products that help in trending applications such as bioengineering or facial rejuvenation. With age, facial skin is bound to lose subcutaneous fat naturally and
2017 - 2022: Injectable Targeted Therapy Global Market
Researchmoz added Most up-to-date research on "2017 - 2022: Injectable Targeted Therapy Global Market" to its huge collection of research reports. Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease